 |
Amyl Therapeutics
Last updated: January 17, 2024
CEO Pierre Vandepapelière
Country: Belgium | Funding: €29.7M (+)
Website: https://www.amyltx.com/
Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases
Website: https://www.amyltx.com/
Amyl Therapeutics unique technology offers a curative solution for all forms of amyloid mediated diseases